Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema

Clinical trial NCT05512962 · COMPLETED

Trial details

NCT number: NCT05512962
Sponsor: Oxular Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2022-08-31
Primary completion: 2023-11-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.